Skip to main navigation Skip to search Skip to main content

Enzalutamide (formerly MDV3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients

  • Technical University of Munich

Research output: Contribution to journalEditorial

1 Scopus citations
Original languageEnglish
Pages (from-to)92-93
Number of pages2
JournalTranslational Andrology and Urology
Volume2
Issue number2
DOIs
StatePublished - Jun 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this